TME Alteration in HER2 Positive Breast Cancer

NCT06533670 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-positive Breast Cancer
Chemotherapy Effect

Sponsor

Seoul National University Hospital